Stock Fundamentals

Company Information

Company Name
Atossa Genetics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US04962H5063
CIK: 0001488039
CUSIP: 04962H506
Currency: USD
Full Time Employees: 16
Phone: 206 588 0256
Fiscal Year End: December
IPO Date: Nov 08, 2012
Description:

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States. Its lead drug candidate is oral (Z)-endoxifen, a selective estrogen receptor modulator and selective estrogen receptor degrader currently in Phase 2 clinical development for the treatment and reduction of risk of breast cancer, as well as in other therapeutic areas. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.

Address:

448 NW Market Street, Seattle, WA, United States, 98107

Directors & Officers

Name Title Year Born
Dr. Steven C. Quay FCAP, M.D., Ph.D. Chairman, CEO & President 1951
Mr. Mark J. Daniel CPA Chief Financial Officer 1977
Ms. Janet Rose Rea MSPH, RAC Senior Vice President of Research & Development NA
Ms. Delly Behen P.H.R. Senior Vice President of Business Operations NA
Dr. Richard Graydon M.D., Ph.D. Interim Chief Medical Officer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
May 21, 2025 Steven C Quay N/A Purchase 749.00 $13.20 $9.89K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 6.15M Dec 31, 2025 4.76% $0.00 1.14%
Ameriprise Financial Inc 255.13K Mar 31, 2026 2.96% $0.00 0.96%
BlackRock Inc 133.17K Mar 31, 2026 1.55% $0.00 0.01%
Renaissance Technologies Corp 109.01K Mar 31, 2026 1.27% $0.00 -20.73%
Geode Capital Management, LLC 97.06K Mar 31, 2026 1.13% $0.00 6.13%
UBS Group AG 92.03K Mar 31, 2026 1.07% $0.00 254.00%
Millennium Management LLC 66.74K Mar 31, 2026 0.78% $0.00 -19.45%
State Street Corp 39.76K Mar 31, 2026 0.46% $0.00 0.00%
Northern Trust Corp 19.22K Mar 31, 2026 0.22% $0.00 -0.01%
Two Sigma Advisers, LLC 18.30K Dec 31, 2025 0.01% $0.00 0.00%
Greenberg Financial Group 18.22K Dec 31, 2025 0.01% $0.00 0.00%
Morgan Stanley - Brokerage Accounts 16.20K Mar 31, 2026 0.19% $0.00 295.17%
Goss Wealth Management LLC 5.00K Dec 31, 2025 0.00% $0.00 0.00%
JONES FINANCIAL COMPANIES LLLP 2.06K Mar 31, 2026 0.02% $0.00 4,285.11%
Tower Research Capital LLC 863.00 Mar 31, 2026 0.01% $0.00 223.22%
Royal Bank of Canada 644.00 Mar 31, 2026 0.01% $0.00 922.22%
Advisor Group Holdings, Inc. 587.00 Mar 31, 2026 0.01% $0.00 -0.51%
JPMorgan Chase & Co 383.00 Mar 31, 2026 0.00% $0.00 -84.91%
Rockefeller Capital Management L.P. 353.00 Mar 31, 2026 0.00% $0.00 6.01%
Wells Fargo & Co 296.00 Mar 31, 2026 0.00% $0.00 4,833.33%

Shares Statistics

Shares Outstanding: 8.61M
Shares Float: 8.58M
% Insiders: 140.80%
% Institutions: 1,888.40%
Short % Float: 3.97%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Extended Equity Market Fund E 279.47K 0.22% ▲ 0.00% Dec 31, 2025
2 Blackrock Extended Mkt Fund CF 279.47K 0.22% ▲ 0.00% Dec 31, 2025
3 Extended Equity Market Fund B 279.47K 0.22% ▲ 0.00% Dec 31, 2025
4 Vanguard Total Stock Mkt Idx Inv 256.14K 2.97% ▲ 0.00% Apr 30, 2026
5 Columbia Small Cap Value Discovery Fund 189.23K 2.20% ▲ 4.19% Mar 31, 2026
6 Vanguard Institutional Extnd Mkt Idx Tr 99.42K 1.15% ▲ 15.04% Apr 30, 2026
7 U.S. Equity Market Fund 63.32K 0.05% ▲ 0.00% Dec 31, 2025
8 Blackrock US Eq Mkt Fund CF 63.32K 0.05% ▲ 0.00% Dec 31, 2025
9 U.S. Equity Market Fund B 63.32K 0.05% ▲ 0.00% Dec 31, 2025
10 Fidelity Extended Market Index 46.58K 0.54% ▼ 0.43% Mar 31, 2026

Valuation Metrics

Enterprise Value: $12.29M
Trailing P/E: 0.00
Forward P/E: 7.04

Financial Highlights

Market Cap: $40.47M
EBITDA: $-39.58M
PEG Ratio: $0.00
Book Value: $3.54
Earnings/Share: $-4.37
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -45.54%
ROE (TTM): -78.58%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 5.53x 0.00x 0.17x N/A 0.00x
2024-12-31 14.99x 0.00x 0.06x N/A 0.00x
2023-12-31 17.61x 0.00x 0.05x N/A 0.00x
2022-12-31 21.23x 0.00x 0.05x -3,461.38x 0.00x
2021-12-31 45.18x 0.00x 0.02x -241.42x 0.00x
2020-12-31 2.73x 0.00x 0.37x -15.56x 0.00x
2019-12-31 10.83x 0.01x 0.09x N/A 0.00x
2018-12-31 3.96x 0.00x 0.25x N/A 0.00x
2017-12-31 6.45x 0.00x 0.15x -37.28x 0.00x
2016-12-31 3.11x 0.00x 0.25x N/A 0.00x
2015-12-31 1.72x 0.00x 0.40x N/A 0.00x
2014-12-31 4.01x 0.01x 0.19x -771.83x -0.01x
2013-12-31 5.27x 0.00x 0.12x -29,957.34x 0.00x
2012-12-31 1.21x 0.00x 0.24x -421.02x 0.00x
2011-12-31 1.95x 0.64x 0.49x -190.60x -0.29x
2010-12-31 0.01x -0.22x 57.75x -117.96x -0.17x
2009-12-31 1.57x 0.16x 0.63x N/A -0.04x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ATOS.US!